Syphilis Diagnostics Market to 2024: Trends, Business Strategies and Opportunities with Key Players Analysis

Global Syphilis Diagnostics Market: Overview

With syphilis continuing to be a global concern, the market for syphilis diagnostics is likely to expand tremendously in the forthcoming years. The rising count of unprotected sex, together with the augmenting rate of anonymous sex, sex under the influence of various drugs, and sex with multiple partners, are the main factors behind the increasing cases of syphilis across the world. Pregnant women are highly susceptible to syphilis and it can lead to various congenital abnormalities in pregnancy, such as stillbirth and abortions.

This research study attempts to present a comprehensive overview of the global market for syphilis diagnostics on the basis of its historical and current performance. The key driving forces, restraining factors, prominent trends, challenges, opportunities, and the future prospects of this market have also been examined thoroughly in this market report.

Read Full Report: http://www.transparencymarketresearch.com/syphilis-diagnostics-market.html

Global Syphilis Diagnostics Market: Trends and Opportunities

The worldwide market for syphilis diagnostics is heavily influenced by the rising count of syphilis affected patients. According to the WHO, nearly 36 million cases of syphilis were registered globally in 2013 and more than 11 million new cases are being recorded every year.

The uptake of new technologies and ongoing development of novel assays are also driving the growth of this market. However, the high cost associated with the diagnostic tests and the regulatory constraints may hamper the market from growing steadily in the near future.

Diagnostic imaging, monoclonal antibodies, molecular diagnostics, gel micro-droplets, immunoassays, flow cytometry, differential light scattering, liposomes, and chromatography have emerged as the most-preferred syphilis diagnostic technologies across the world. Currently, these diagnostic techniques are finding a widespread application in public health labs, commercial/private labs, blood banks, physician offices, and hospitals and this trend is likely to remain so in the years to come.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2140

Global Syphilis Diagnostics Market: Geographical Analysis

The global market for syphilis diagnostics is spread Europe, Asia Pacific, North America, and the Rest of the World. Boosted by the increasing incidence of unprotected sex, North America and Europe have been reporting a high prevalence of syphilis, which in turn, is leading to a remarkable increase in the demand for syphilis diagnostics in these regions. Both the regions are likely to remain at the forefront of the worldwide market for syphilis over the period of forecast.

Apart from this, due to the increasing prevalence of syphilis in China, India, and other South East Asian countries, Asia Pacific is also expected to witness an upswing in the uptake of syphilis diagnostic techniques in the near future. The rising awareness regarding STDs and general health is also projected to propel this regional market over the next few years.

Companies mentioned in the research report

Some of the leading companies competing in the global market for syphilis diagnostics are Abbott Laboratories, Beckman Coulter and Co., Affymetrix, Cephaid, Bio-Rad Laboratories Inc., Diamedix Corp., BioMerieux, DiaSorin, Eiken Chemical Co. Ltd., Novartis International AG, Ortho Clinical Diagnostics, ThermoFisher Scientific, F. Hoffman-La Roche Ltd., SeraCare LifeSciences, and Quagen.

Micro Guide Catheters Market - New Business Opportunities & Investment Research Report 2024

Micro guide catheters offer several advantages to their users over the conventional counterparts. With the healthcare industry realizing the benefits offered by these, the uptake is poised to rise at an incredible pace thus boosting the global market for micro guide catheters. In a report, titled “Micro Guide Catheters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024,” uncovers the consumption patterns and latest trends influencing the market. Furthermore, an in-depth analysis of the key factors encouraging the market and those that pose challenge to its trajectory is also provided in the report.

The report also includes objective qualitative and quantitative inputs by industry veterans aimed at providing the market stakeholders with better perspective of the prevailing dynamics and refined forecasts. Industry-leading analytical tools such as Porter’s five forces, market attractiveness analysis, value chain analysis, and SWOT analysis are conducted to ensure clients get the most current market data.

Read Full Report: http://www.transparencymarketresearch.com/micro-guide-catheters-market.html

Micro guide catheters are used in increasingly difficult lesions in human body through the most complex vessels, ducts, or cavities. These catheters are mostly used in neurovascular and cardiovascular procedures. They are designed using the glide technology and come with a hydrophilic coating in addition to a stainless steel braid and gold marker. In order to gain more traction, the leading companies have been focusing on the development of advanced micro guide catheters to offer surgeons with superior support and wire handling thus assisting them in the treatment of the most damaged lesions.

Primarily the demand for micro guide catheters is increasing due to the improved tensile strength and better reliability it provides. The growing awareness about the benefits that micro guide catheters is giving significant impetus to the market. Besides this, the flexibility and improved guidewire control offered by these catheters also serve as the key growth drivers of the market.

With an increasing number of companies foraying into the market through product launches and investment in research and development activities, the market is poised to grow at an exponential pace through the forecast period between 2016 and 2024. Currently, the use of micro catheters in the field of cardiology has greatly increased in response to the soaring prevalence of cardiovascular diseases around the world. Furthermore, the use of the medical device in the treatment of conditions such as vascular malformations, arterial embolism, pulmonary or venal embolism, hyper vascularized tumors and uterine fibroids has also significantly bolstered opportunities for the global micro guide catheters market.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11966

On the downside, risks associated with the materials used in the catheter and other functional concerns may threaten the market’s trajectory to an extent. Nevertheless, as potential technological advancements promise to mitigate these issues, the market is heading towards sustainable growth in the future.

Regionally, North America currently holds dominance in the global micro guide catheters market. The continuously rising investment in the research and development of advanced treatment methodologies and the presence of a sophisticated healthcare infrastructure have been aiding the expansion of the market in North America. Furthermore, the market is also expected to witness lucrative opportunities across Asia Pacific.

Some of the leading companies likely to benefit from the aforementioned trends are Terumo Europe N.V., Merit Medical Systems Inc., LuMend Corporation, ASAHI INTECC Company Limited, Lake Region Manufacturing Inc., Volcano Corporation, Boston Scientific Corporation, Micro Therapeutics Inc., and Covidien AG.

Smart Syringes Market: Prime end users are hospitals and health maintenance organizations (HMOs)

Smart Syringes Market: Overview

Smart syringes are gaining significant popularity around the world. These syringes are equipped with safety mechanisms, preventing their reutilization, and hence controlling unsafe injection practices.

In the recent times, the incidence of infections, owing to unsafe injection practices, has increased substantially. According to the WHO, around 1.7 million people were infected with the hepatitis B virus, almost 0.3 million were infected with hepatitis C virus, and approximately 34,000 individuals were reported to be infected with HIV due to unsafe injections in 2014. These cases, together with rising reports of needlestick injuries, have remarkably boosted the demand for smart syringes worldwide over the years.

Read Full Report: http://www.transparencymarketresearch.com/smart-syringes-market.html

This research report on the global market for smart syringes provides a comprehensive analysis of this market, taking its current as well as historical performance into consideration. Analysts have also predicted the future status of this market in this study by examining its future prospects and current and imminent major trends.

Smart Syringes Market: Key Trends and Opportunities

Smart syringes are generally utilized in vaccination, drug delivery, and blood specimen collection, among which drug delivery is the most common application area for these syringes. The prime end users of smart syringes are hospitals and health maintenance organizations (HMOs), psychiatrists, and diabetic patients. The demand for these syringes has been the highest from hospitals and HMOs over the last few years.

Auto-disabled (AD) syringes are attracting the highest demand among all the smart syringe products due to their single-use characteristic. These syringes find maximum application in the routine administration of medicines and fluids, owing to which the demand for them is likely to remain high over the next few years.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12707

The passive safety syringes segment is also expected to gain significant impetus in the coming years. The ease of use, the improved patient safety ensured by the automated activation of the safety feature, and the efficient protection from the transmission of infections offered by these syringes are anticipated to fuel their demand in the future.

Smart Syringes Market: Region-wise Outlook

Geographically, the worldwide smart syringes market can be broadly segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. Currently, North America is leading the global market. Rising concerns about needlestick injuries, constant advancements in health-care practices, and the presence of a well-developed medical and health-care infrastructure in this region are driving the smart syringes market in North America.

Apart from this, Asia Pacific is likely to report a significant rise in its market share over the next few years. The rapid growth in disposable income has raised the level of health-care expenditure in this region. Awareness regarding safe injection practices is also rising. Several initiatives by the WHO and local governments to reduce needlestick injuries in order to curb various infections are projected to promote the usage of smart syringes in this region substantially in the near future. All these factors are expected to fuel the Asia Pacific smart syringes market in the coming years.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12707

Smart Syringes Market: Competitive Outlook

Some of the leading participants in the global market for smart syringes are Smiths Group Plc, B. Braun Melsungen AG, Baxter International Inc., Terumo Medical Corp., Retractable Technologies Inc, Unilife Corp., Revolutions Medical Corp., Medtronic Plc (Covidien), and Becton, and Dickinson and Co.

The high level of unmet needs in several emerging economies have provided market participants huge scope for growth. The growing trend of safe injection practices in medical and health-care systems globally is also presenting lucrative opportunities.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Live Cell Imaging Market - Latest Trends & Insights 2024

A market intelligence report by Transparency Market Research presents a comprehensive analysis of the global market for live cell imaging technologies.

The study of living cells with the help of detailed pictures produced by imaging systems such as microscopes and high content screening systems is called live cell imaging. Over the past few years, the use of LCI techniques across a number of research areas has consistently increased owing to the many benefits these techniques offer. LCI techniques are known to produce an enhanced view of a number of biological functions by giving insights into cellular dynamics of cellular processes.

Read Full Report: http://www.transparencymarketresearch.com/live-cell-imaging-market.html

LCI techniques are changing the way in which proteins, molecular interactions, cells, and a multitude of biological processes are studied. These techniques are aiding scientists to monitor in real time a variety of cellular structures and internal structures, thus providing a better understanding of dynamic processes and cellular structures, which is crucial for properly studying many aspects of cell biology.

The information compiled in the report finds huge scope in drug discovery, genetics, cytology, neurobiology, microbiology, and immunology. The rising adoption of LCI techniques in these fields, the rising popularity of high content screening technologies in the field of drug discovery, the rising prevalence of a number of cancers, and the rising volumes of funds by government bodies for cell-based research are driving the global market for LCI techniques.

However, certain factors such as the high cost of sophisticated screening systems and shortage of skilled professionals are hindering the overall development of the global live cell imaging market to a certain extent.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7688

The report segments the market on the basis of four criteria: product type, technology, application, and geography.

On the basis of product type, the market is segmented into consumables, equipment, and software. Live cell imaging equipment are further classified into cell analyzers, standalone systems, image capturing devices, and microscopes. Of these, the segment of microscopes currently holds the largest share of the overall market. The consumables segment is bifurcated into assay kits, reagents, and media. Of these, the segment of assay kits currently holds the largest share in the overall LCI consumables market.

Technology-wise, the global live cell imaging market is segmented into FRAP (Fluorescence recovery after photo bleaching), PALM (Photo activated localization microscopy), TD-FLIM (Time-domain Fluorescence Lifetime Imaging Microscopy), FRET (Forster resonance energy transfer), TIRF (Total internal reflection fluorescence microscopy), and MPE (multiphoton excitation microscopy). On the basis of application, the market is segmented into wound healing, angiogenesis, chemotaxis, and cell culture under flow.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=7688

The report also presents a detailed overview of the competitive landscape of the global live cell imaging market with the help of detailed business profiles and SWOT analysis of some of the key companies in the market, recent development, and analysis of activities such as mergers and acquisitions, etc.

Some of the key companies in the market are Leica Microsystems, Carl Zeiss AG, Nikon Corporation, Molecular Devices, LCC, Becton, Dickinson and Company, Thermo Fisher Scientific, PerkinElmer, Inc., Sigma-Aldrich Corporation, and GE Healthcare.

Peripheral Intravenous Catheters Market - Latest Innovations, Drivers, Restraints, Challenges and Forecast 2016 - 2024

Global Peripheral Intravenous Catheter Market: Overview

A small tube placed into peripheral vein in order to administer medication directly into the circulation is known as a peripheral intravenous (IV) catheter. In addition to medication administration, peripheral intravenous (IV) catheters are used to withdraw blood from veins for testing. Advanced peripheral intravenous (IV) catheters are equipped with additional safety features to avoid needlestick injuries. Due to their direct contact with the circulatory system, peripheral intravenous (IV) catheters are prepared with non irritant material such as silicone, which do not have side effects even when peripheral intravenous catheters are left in contact with the circulatory system for several months or weeks.

Global Peripheral Intravenous Catheter Market: Drivers and Restraints

Peripheral intravenous (IV) catheters are commonly used for vascular access. Medicine administered through a peripheral intravenous (IV) catheter enters directly into the blood flow and thus shows rapid action. With the advantage of rapid action, peripheral intravenous (IV) catheters are commonly used in emergency patients, surgical patients and patients suffering from vomiting, pediatric patients, unconscious patients and the elderly population, who face difficulty in swallowing medicines. Factors such as aging of population and advancement in surgical and treatment technologies resulting in increased surgical procedures are driving the global peripheral intravenous (IV) catheters market towards growth. On the other hand, factors such as high cost of closed catheters, painful insertion and need of trained medical professional to use peripheral intravenous (IV) catheters are restraining the growth of the global peripheral intravenous (IV) catheters market. Based on the type of catheters commercially available, the global peripheral intravenous (IV) catheters market is segmented as follows:

• Integrated/Closed catheters
• Peripheral insertion catheters

Use of integrated/closed intravenous (IV) catheters is rapidly increasing over conventional intravenous (IV) catheters due to capacity of integrated catheters to apply power while injecting medicine in the circulation. Integrated intravenous (IV) catheters are used for injecting contrast media into the circulation system prior to computed tomography (CT) imaging. On the other hand, high cost of the integrated peripheral intravenous (IV) catheters is restraining the growth of integrated peripheral intravenous (IV) catheters market in economically backward markets.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12206

Global Peripheral Intravenous Catheter Market: Regional Dynamics

Geographically, the global peripheral intravenous (IV) catheters market is segmented into North America, Europe, Asia-Pacific and Rest of the world (ROW). Currently, North America is leading the global peripheral intravenous (IV) catheters market and is followed by Europe. Factors such as existence of a large pool of geriatric population, highly developed healthcare infrastructure, high healthcare spending and advancement in technology resulting in higher rates of surgical procedures in this region are boosting the growth of the peripheral intravenous (IV) catheters market in these regions. Asia-Pacific is the fastest growing market for peripheral intravenous (IV) catheters due to increasing disposable income, rapidly improving healthcare infrastructure and rapidly growing medical tourism industry in this region. In addition, countries such as China and India have the largest population pool in the world and thus the large geriatric population of both the countries will lead to an increasing patient population in the near future. Some of the players contributing to the peripheral intravenous (IV) catheters market include Terumo Corporation, B. Braun Melsungen AG, Smiths Medical, Becton, Dickenson and Co., Teleflex Inc., C.R. Bard Inc., Tangent Medical Technologies, Vygon SA, Argon Medical Devices Inc., Vascular Pathways Inc., Medical Components Inc. and VIGMED AB.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Virology and Bacteriology Testing Market: Global Markets & Advanced Technologies

Virus is the complexes of nucleic acid and protein. Virology is the study of viruses that have the capacity for replication in animal, plant and bacterial cells. Bacteriology is the study of bacteria which involves the identification, classification and characterization of various bacterial species. Viral parasite results in changes in the cell, especially in its antigenicity and directs the host cells metabolism to produce new virus particles which may cause cellular death. Overall, viruses are reported in two basic types, the one that consist a genome of DNA and the one that consist a genome of RNA. Bacterial and viral infections, can lead to mild, moderate and severe diseases. It is observed that, infectious disease testing is rapidly growing for the in vitro diagnostics industry. The etiology for few of the infections is still unknown, however for others the causative microorganisms are present in a very minute concentrations.

Read Full Report: http://www.transparencymarketresearch.com/virology-bacteriology-testing-market.html

Based on technology, the virology and bacteriology testing market can be segmented as follows:

• Molecular diagnostics
• Monoclonal antibodies
• Immunoassays
• Differential light scattering
• Information technology
• Artificial intelligence
• Liposomes
• Flow cytometry
• Chromatography
• Diagnostic imaging
• Gel microdroplets

Based on end user, the virology and bacteriology testing market can be segmented as follows:

• Hospital
• Clinics
• Laboratories
• Diagnostic centers
• Blood banks

Based on disease, the virology and bacteriology testing market can be segmented as follows:

• Urinary tract infections
• Respiratory diseases
• Bloodstream infections
• Sexually transmitted diseases (STDs)
• STD caused by bacteria
• STDs caused by viruses
• Gastrointestinal diseases
• Periodontal diseases

Other diseases (cardiovascular disease, central nervous system infections, connective tissue & joint diseases, and skin diseases, among others)

Rising awareness of tuberculosis in the developing countries leads to significant growth potential for respiratory disease segment. Millions of people are affected by periodontal diseases worldwide, in which very few receive proper treatment. The causing agent of periodontal diseases is unknown, whereas millions of people are affected worldwide of which very few people receive proper treatment for the disease. Gastrointestinal diseases are caused by huge number of microbes such as E. coli, Salmonella, Shigella, Campylobacter, Clostridium, virus like Norwalk agent, Rotaviruses and parasites like Giardia, Entamoeba, and Ascaris.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14063

Region wise, the virology and bacteriology testing market can be segmented as: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The regions are further analyzed by major countries contributing to the market. Overall, the virology and bacteriology industry was predominantly influenced by ebola, MERS, and hepatitis C viruses in 2015. Currently, Zika virus dominates the research and development work worldwide as its outbreak has been observed (first time) among the patient in the year 2016 (Mid). According to Center for Disease Control and Prevention nearly 2,246 cases of Zika virus were reported in the United States (August 2016).

Key players operating in the virology and bacteriology testing market includes Abbot, Grifols, Diamedix Inc., Diasorin, Fujirebio Diagnostics Inc., Thermo Fisher Scientific Inc., bioMerieux SA, Cepheid, Bio-Rad Laboratories Inc., Eiken Chemical Co Ltd., Hologic Inc., Qiagen, F. Hoffmann-La RocheLtd., Scienion AG, Sequenom, Siemens AG, Leica Biosystems Nussloch GmbH. and others.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Anesthesia Video Laryngoscope Market - New Business Opportunities & Investment Research Report 2024

Video laryngoscope device is used to view anatomical structure of the larynx for detailed examination.

The visualization of the larynx is done with a digital laryngoscope or fiber optic inserted transorally or transnasally. The images are recorded for a more detailed examination. Larynx examination can be performed by indirect laryngoscopy and direct laryngoscopy. Direct laryngoscopy includes setting of tube (laryngoscope) in the back of the throat which helps the specialist to inspect the throat and eliminate the contaminated tissue for biopsy. The process of tissue removal (biopsy) is normally done after the administration of anesthesia. Indirect laryngoscopy predominantly includes visualization of upper tracheal rings, vocal cords, and larynx. Growing awareness among healthcare professionals about technologically advanced video laryngoscopes and its advantages over traditional laryngoscopes are helping in expanded use beyond hospital settings which are the factors impelling the growth of the global anesthesia video laryngoscope market. Recently, several companies have started developing video laryngoscope products which are self-contained, lightweight, wireless, and battery operated as they are easy to operate. Increasing use during robot-assisted intubation is a trending factor which is expected to spur the global anesthesia video laryngoscope market growth through 2024. Also, the adoption of advanced products such as portable anesthesia video laryngoscopes is high owing to similar functions and configurations such as conventional curved and angulated laryngoscope without the extra difficulty of training that increases physician’s preference for anesthesia video laryngoscope devices. However, some challenges faced during the use of anesthesia video laryngoscopes are voice pitch complications, breathing problems, internal bleeding, and irritation. Also, high cost of devices and availability of alternative devices are certain challenges which may hamper the global anesthesia video laryngoscope market growth.

Read Full Report: http://www.transparencymarketresearch.com/anesthesia-video-laryngoscope-market.html

The global anesthesia video laryngoscope market has been segmented by type of laryngoscopy, by end user and by geography. In terms of laryngoscopy type, anesthesia video laryngoscope has been categorized into rigid laryngoscope and transnasal flexible laryngoscope. Furthermore, rigid laryngoscope will dominate the video laryngoscope market in terms of value in 2015. The rising awareness regarding minimally invasive surgery along with the use of video laryngoscopes compels the growth of the market. Based on end user segmentation, the anesthesia video laryngoscope has been categorized into diagnostic laboratories, hospitals, and ENT clinics. Among the end user type of anesthesia laryngoscope, hospitals are expected to contribute maximum share as compared to diagnostic laboratories and ENT clinics.

Depending on geographic segmentation, the global anesthesia video laryngoscopes market is segmented into five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to contribute significant share in the global market for anesthesia video laryngoscope owing to extensive awareness of advanced products and research & development activities in the region. Presence of well-established healthcare organization, promising government initiatives in implementing anesthesia video laryngoscope in the surgeries and constantly improving reimbursement scenario expected to propel the market growth during the forecast period. Europe was second largest contributor in the anesthesia video laryngoscope market due to enhanced healthcare processes and increased implementation of minimally invasive surgeries in the region. Asia Pacific and Latin America are expected to gain market share at rapid pace in the forecast period. The major factors which are expected drive the market growth in Asia Pacific include the improving healthcare infrastructure and the increasing awareness levels for surgery treatment options. Latin American countries such as Brazil and Mexico are expected to have considerable potential for driving the market growth due to high disposable income and evolving medical structure. The major players operating in this market include Ambu A/S, Medtronic plc, Clarus Medical LLC, BOMIMED, Teleflex Incorporated, Verathon Inc., KARL STORZ GmbH & Co. KG, Venner Medical (Deutschland) GmbH, and XION GmbH among other significant players worldwide.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16511

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Ophthalmic Ultrasound Systems Market grows with high demands for advanced radiation free ophthalmic imaging technologies

Ophthalmic ultrasound systems play an important in the clinical assessment of various orbital and ocular diseases. These technologies are majorly used for examining the back of the eye in patients who have cloudy ocular conditions such as corneal clouding, vitreous hemorrhage and cataract. Currently, the market for ophthalmic ultrasound systems is considerably promising and profitable due to the increase usage of ophthalmic ultrasound systems along with escalating incidence rates of ocular diseases the market is expected to grow substantially.

The major technologies and types of ophthalmic ultrasound systems are as follows:

• A-Scan systems
• B-Scan systems
• Ultrasound Biomicroscopy (UBM)
• Pachymeters

Based on the type of modalities the market for ophthalmic ultrasound systems can be segmented as follows:

• Portable
• Hand held
• On platform systems

In terms of regional distribution, North America followed by Europe account for the largest market share of ophthalmic ultrasound systems market due to the high usage and adoption rate of ultrasound imaging technologies in diagnostic centers and hospitals. According to the Centers for Disease Control and Prevention (CDC), about 20.5 million people in the U.S. of age 40 years and over are suffering from cataract in one or both eyes and around 6.1 million people have had their lens removed surgically. Moreover, the organization predicts that the number of people suffering from cataract would increase to nearly 30.1 million by 2020.In addition, other regions such as Asia Pacific, Latin America as well as Middle East, are expected to be the potential markets in the near future. Due to the high adoption rate of advanced ultrasound imaging systems and exponentially growing healthcare industry, these regions are expected to be the potential market in the near future.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6583

Globally, the overall ophthalmic ultrasound systems market is witnessing a substantial pressure and rapid development. Moreover, high demands for advanced radiation free ophthalmic imaging technologies; and rising incidence of ophthalmologic disorders are contributing to the growth of the overall ophthalmic ultrasound systems market. In addition, increasing incidence of eye disorders such as cataract, glaucoma and age-related macular degeneration (AMD) are expected to amplify the demand for ophthalmic ultrasound systems across the globe. According to the World Health Organization (WHO), in 2010, cataract was responsible for 51% of world blindness. Moreover, advantage of these ophthalmic ultrasound systems such as capability to provide in-depth real-time images of components of eyes is driving the growth of the overall ophthalmic ultrasound systems market. Furthermore, huge application scope of the advance ophthalmic ultrasound systems, operator and patient safety as well as patient comfort are also some factors that are driving the growth of this market. However, market-restraining factors such as high installation and development cost coupled with stringent regulatory policies might impede the growth of the ophthalmic ultrasound systems market.

At present, the global ophthalmic ultrasound systems market is highly fragmented and competitive owing to the presence of many established as well as emerging players in the ophthalmic ultrasound systems market. The market is expected to witness a significantly high growth rate due to the increasing usage of ophthalmic imaging technologies and diagnostic testing services in the field of ophthalmology and healthcare industry. Major companies operating in the field of ophthalmic ultrasound systems market are Ellex Medical Lasers Ltd., Optikon 2000 S.p.A., Optos plc, Quantel Medical, Reichert, Inc., Sonomed Escalon and others.

Healthcare Information Exchange Market to 2023: Trends, Business Strategies and Opportunities with Key Players Analysis

A new report by Transparency Market Research states that the global healthcare information exchange market is likely to benefit due to the rising collaborations and mergers between leading players and the startup companies. The rising need to have easy access to patient information and the increasing demand for enhanced healthcare are two of the factors, which can be credited for the growth of the global healthcare information exchange market.

As per the research conducted at Sushoo Health Information Exchange, the current methods to exchange patient information costs around US$17,160 per year, for a single clinician practice. This creates demand for efficient storage and interchange of patient information. This has boosted the demand for healthcare information exchange systems. The demand for healthcare information exchange systems is expected to increase from doctors, pharmacists, patients, nurses, and laboratories.

The report, titled “Healthcare Information Exchange Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” states that the market is likely to benefit from the rising amalgamations and partnerships between small-scale and large-scale companies. New companies are focusing on adding innovations in the existing healthcare information exchange systems. Some of the key companies listed in the report are AT&T, Inc., IBM Corporation, Medicity, CareEvolution Inc., Orion Health, GE Healthcare, InterSystems Corporation, Siemens AG, and Cerner Corporation.

Technology has assisted the startup companies to introduce cost effective software and systems to effectively share patient information across various platforms. However, high initial investment, complex technologies, and less ROI are some of the factor expected to hamper the growth of the global healthcare information exchange market.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5339

For a detailed analysis, the global healthcare information exchange market is segmented on the basis of vendor type, implementation model, region, and setup type. By setup type, the global market for healthcare information exchange is divided into public and private segments. By implementation type, the market is classified into a decentralized model, hybrid model, and a centralized model. Based on region, the global healthcare information exchange market is divided into Europe, North America, Latin America, Asia Pacific, and Rest of the World. In 2013, the global market was dominated by North America owing to the existence of most of the leading companies in the United States. However, Asia Pacific is likely to be the second largest market for healthcare information exchange, predicts the analysts.

The demand for customized healthcare information exchange systems is expected to increase in most of the emerging nations, which is a boon for the leading companies.

Proton Therapy Market: Global Markets & Advanced Technologies

A new market research report by Transparency Market Research is titled “Proton Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019.” The report studies the market from various angles to present a comprehensive picture. It details key product segments and the technological growth trajectory to understand the industry’s growth prospects.

It gauges the current competitive landscape by leveraging Porter’s Five Forces analysis, which is a study of supplier power, buyer power, competitive rivalry, threat of substitution, and threat of new entry. The report also leverages SWOT analysis, which studies the strengths and weaknesses of key players to uncover opportunities and threats awaiting them. The report presents a detailed value chain analysis and also uses distinctive graphics to highlight key facts about the market. 

Read Full Report: http://www.transparencymarketresearch.com/proton-therapy-market.html

Proton therapy, also known as proton beam therapy, uses positively charged particles called protons in place of x-rays to treat cancer. One key advantage of proton therapy over x-rays is that it targets the tumor without affecting or damaging adjoining healthy tissues. Hence, it minimizes side effects resulting from damage done to other organs and tissues by x-rays, while targeting the affected area. Proton therapy is a non-invasive and painless procedure, which does not hamper the normal life of a patient. It is highly effective for wide array of localized tumors in prostate, bladder, head and neck area, lung, gastro malignancies, spinal cord, ocular tumors, etc. 

As awareness about the benefits of proton therapy grows in the medical fraternity as well as among the general public, the market will grow accordingly. The number of proton therapy centers is already increasing gradually. On account of the newness of the treatment, its growth has not been explosive so far. Only a fraction of eligible patients have been treated using the method till date. Besides, it is an expensive therapy, which only people in the high-income group can afford.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2036

Geography-wise, the market for proton therapy can be divided into Europe, North America, Asia Pacific, and the Rest of the World. Among them, Europe and North America, which have the most advanced healthcare facilities, are the largest markets as they are home to maximum number of proton therapy treatment centers. In fact, the first facility that used proton therapy in 1990 – the Proton Treatment Center at Loma Linda University Medical Center – is based in California, U.S. The Asia Pacific market is expected to receive a push because of new centers being established in Australia, which is likely to eventually generate awareness about the procedure.

There are just a handful of companies involved in developing and manufacturing cyclotrons, synchrotrons and other equipment required by proton therapy centers. Some of them are Hitachi, Ion Beam Applications, Varian Medical Systems, S.A., and Fermilab Scientists.

Medical Devices Market - New Business Opportunities & Investment Research Report 2024

Over the past few years, the global medical devices market has been successful in registering consistent growth. Besides rise in geriatric population, the market has gained considerably from the innovations, changing lifestyle, higher disposable income, and growing awareness about chronic ailments and their potential treatments. Transparency Market Research’s (TMR’s) new report, titled “Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024” forecasts strong growth for the market.

While opportunities witnessed in traditional markets will remain somewhat stagnant due to pricing pressure and toughening regulatory scrutiny, prospects across emerging nations are poised to surge between 2016 and 2024. Decelerating growth witnessed in the healthcare industry of Latin America and Eastern Europe will pose challenge to enterprises seeking to explore opportunities therein. However, despite remaining difficult to access, Asia Pacific will continue exhibiting lucrative opportunities for enterprises to gain new markets through the course of the forecast period.

Based on type, the most common types of medical devices available in the market at present includes molecular diagnostic devices, diagnostic imaging devices, drug delivery devices, monitoring and surgical devices, neurostimulation devices, bioimpants, and others such as syringes, gloves, surgical and medical sterilizers, and needles.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11984

The global healthcare industry is currently undergoing massive transformation and the market for medical devices is at the center of the healthcare revolution. With practices such as DIY (do-it-yourself) healthcare, mobile healthcare, and decentralized healthcare making headway, vendors are expected to be treated with myriad opportunities as well as challenges in the near future.

For instance, the adoption of health and fitness-related applications for smartphones has significantly increased over the past few years. This is indicative of the healthcare sector’s intent of going mobile to ensure better access and improved patient care. Furthermore, consumers have become significantly aware of the user-friendliness of DIY medical devices, which is expected to aid the market’s expansion in the coming years. The increasing demand for minimally-invasive surgeries is also expected to pave way for innovations in the market thus supporting its growth.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=11984

In addition, the growing importance of wireless connectivity in comparison to face-to-face communications is witnessed in the medical device market. Doctors nowadays see wireless communication as an effective medium to monitor patients better. Besides this, the trend of take-home medical devices is on the rise. These factors are expected to boost the global medical devices market in the coming years. The rising demand for remote healthcare services will also aid the market’s expansion.

Some of the companies gaining from the recent market developments are Toshiba Medical Systems, Johnson & Johnson, Smith and Nephew, Siemens Healthcare, GE Healthcare, St. Jude Medical, Inc., Stryker Corporation, Boston Scientific Corporation, Philips Healthcare, and Biomet, Inc.

Laser Capture Microdissection Market Offering High-growth Opportunities for Market Players

Laser Capture Microdissection Market: Overview

Laser capture microdissection (LCM) technology is a contamination free procedure for obtaining subpopulations of tissue cells under direct microscopic visualization. Furthermore, laser-capture microdissection technology isolates specific cells by dissecting unwanted cells. Laser capture microdissection technology harvests the cells of interest directly to give pure enriched cells. This technology helps in preserving the genuine morphology of the dissected cell or tissue sample. The laser capture microdissection technology by type can be segmented into software, instruments, consumables, and services. Furthermore, the market for laser capture microdissection by system can be segmented into infrared LCM, ultraviolet LCM and Immunofluorescence LCM. In addition, by end users the laser capture microdissection market can be segmented into biotechnology and pharmaceutical companies, hospitals and government research institutes among others. Moreover, by application the market can be segmented into research and development and diagnostics among others.

The laser capture microdissection market by geography has been segmented into Europe, Asia Pacific, North America and Rest of the World (RoW).

Laser Capture Microdissection Market: Trends and Opportunities

Increasing expenditure on healthcare along with technological advancement in the field of healthcare is one of the major driving factors for the laser capture microdissection market. Furthermore, increasing information regarding the technical advantages obtained from laser-capture microdissection techniques is fueling the market at the global level. In addition, growing funding and expenditure on research and development activities of companies involved in this market is stimulating the growth of this market. High maintenance and manufacturing cost of accessories and equipment along with lack of expertise professionals in this field is some of the restraining factors which may hinder the growth of this market.

Research and development and diagnostics among others are major application areas of laser-capture microdissection technology. Furthermore, government research institutes and hospitals are major end users of this technology. Moreover, ultraviolet LCM and infrared LCM are leading the market globally. Increasing preference of laser-capture microdissection technology in forensic science and molecular biology under the research and development application segment is one of the major driving factors for the market.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7682

Laser Capture Microdissection Market: Geographical and Competitive Dynamics

With the increasing technological advancement and growing application of laser-capture microdissection (LCM) technology in pharmaceuticals, hospitals and research and development institutes are fueling the market globally. North America dominated the market for laser-capture microdissection in 2014 and is expected to maintain its position over the forecast period 2015 to 2023. U.S. is the major market across North America. Moreover, with the increasing expenditure on research and development activities of companies dealing in this market along with increasing awareness regarding the technological advancement is driving the market for laser-capture microdissection across Asia Pacific. China, Japan, India, contributes in the positive growth of this market across Asia Pacific. Growing application areas of this technology in the fields such as forensic science, diagnostics and molecular biology are having a positive impact on the growing market for laser-capture microdissection in Rest of the World (RoW).

Some of the key players operating in the laser capture microdissection market are Carl Zeiss AG (Germany), Molecular Machines & Industries (Germany), Ocimum Biosolutions LLC (U.S.), DeNova Sciences Pte. Ltd. (Singapore), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Indivumed GmbH (Germany), AvanSci Bio, L.L.C. (U.S.), Theranostics Health, Inc.(U.S.) and 3DHISTECH Ltd. (Hungary) among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Biodegradable Stents Market grows with rising popularity of biodegradable stents for cardiovascular disease management

Global Biodegradable Stents Market: Overview

Stents are extensively used for treating blocked arteries. These tiny and expandable mesh tubes help to keep the arteries open. Metallic stents are the most commonly used stents for the treatment of coronary and peripheral artery diseases. However, these stents have limitations such as the risk of stent thrombosis or a mismatch between the stent and the size of the vessel. While stent thrombosis requires prolonged anti-platelet therapy, the mismatch of a stent with the vessel size leads to a smaller lumen after stent implantation. Furthermore, metallic stents interfere with modern imaging technologies such as multi-slice computerized tomography (MSCT) and magnetic resonance imaging (MRI). As a result, the demand for biodegradable stents has increased as these stents significantly reduce the risks of adverse thrombotic events and completely degrade after a certain period.

On the basis of material, the global biodegradable stents market can be segmented into metallic alloy and polymeric biodegradable stents. Magnesium and iron are commonly used in the manufacture of metallic alloy biodegradable stents. The biocompatibility of the metallic alloy biodegradable stents depends on numerous factors. Biodegradable stents made of magnesium are gaining popularity as they have lower degradation time. Polymeric biodegradable stents are usually made of Poly D, L-lactide/glycolide copolymer (PDLA), Poly-L-Lactic acid (PLLA), polycaprolactone, and Polyglycolic Acid(PGA).

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12464

Global Biodegradable Stents Market: Trends

The growing prevalence of peripheral and coronary artery diseases has boosted the demand for biodegradable stents. According to the World Health Organization (WHO), cardiovascular diseases such as peripheral arterial disease, coronary heart disease, deep vein thrombosis, and congenital heart disease are the primary cause of natural death across the globe. In 2012, an estimated 17.5 million people died from cardiovascular diseases, which translates to 31% of all global deaths. Of these deaths, about 7.4 million were due to coronary heart disease. The rising popularity of biodegradable stents for cardiovascular disease management has propelled the growth of the global biodegradable stents market. Biodegradable stents eliminate the need for dual anti-platelet therapies and treat coronary artery diseases effectively.

The slow adoption rate of stents is the major hindrance in the expansion of the global biodegradable stents market. Furthermore, there are drawbacks associated with the implantation of biodegradable stents. For example, the strength of polymeric biodegradable stents is lower compared to conventional metallic stents. Unfavorable reimbursement policies have also been detrimental to the growth of the market. The global biodegradable stents market has a significant opportunity to grow with extensive research and development activities being carried out by key market players.

Global Biodegradable Stents Market: Region-wise Outlook

The global biodegradable stents market has been segmented into four key regions: Europe, Asia Pacific, North America, and Rest of the World. The growing adoption of biodegradable stents for the treatment of coronary ailments has boosted the growth of the market across North America. The U.S. and Canada are driving the demand for biodegradable stents in North America. In Europe, the U.K., France, Italy, and Germany are contributing significantly to the growth of the market.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12464

During the forecast horizon, Asia Pacific is anticipated to emerge as a potential market for biodegradable stents due to the growing prevalence of various coronary and peripheral heart diseases in the region. India, China, and Japan are the prominent markets for biodegradable stents in this region.

Some of the key players in the global biodegradable stents market are Arterial Remodeling Technologies SA, American Medical Systems Inc., Boston Scientific Corporation, Cedars-Sinai Medical Center, Cordis Corporation, Bristol-Myers Squibb Company, Abbott Laboratories, Amaranth Medical Inc., Kyoto Medical Planning Co. Ltd., REVA Medical Inc., BIOTRONIK SE & Co. KG, Tepha Inc., Xenogenics Corporation, Eurocor GmbH, and Elixir Medical Corporation.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Increasing expenditure on personal grooming also has been boosting the U.S. Scar Treatment Market

U.S. Scar Treatment Market: Overview

Often considered a concept that draws from wound care and first aid, scar treatment has emerged as a niche market promising high growth to medical device manufacturers. However, products used in scar therapy are far more advanced than conventional first-aid adhesives. Driven by innovations, demand in the U.S. scar treatment market is poised to surge exponentially between 2016 and 2024.

A scar is any mark on the skin caused by injury, burns, surgery, acne, or inflammation of tissue. Scars can impact the mental and physical well-being of an individual, resulting in poor self-esteem, depression, embarrassment, and altered social interactions. Scars can be of various types depending on their age, color, shape, and sizes. The incidence of skin problems leading to scar formation is significantly high in the U.S., which is driving the scar treatment market in the country.

Additionally, the U.S. scar treatment market is significantly gaining from the easy availability of technologically advanced products with the capability of fading apparent scars. The growing geriatric population and rising consciousness about appearance among consumers are also aiding the expansion of the scar treatment market in the U.S. Increasing expenditure on personal grooming also has been boosting the U.S. scar treatment market.

A comprehensive overview of the U.S. scar treatment market has been provided in the report. The factors impacting the market’s growth are studied in detail. The report also presents insights into the growth drivers and restraints that are expected to influence the market’s trajectory during the forecast period. Some of the companies operating in the market are profiled in the report to examine the competition prevailing in the U.S. scar treatment market.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12509

U.S. Scar Treatment Market: Key Opportunities and Threats

The increasing disposable income of consumers and rising economic growth are cited as reasons for the revenue generated from the increasing sale of scar treatment products. It is important to note that while the treatment of keloids and burn scars is considered medically important by regulatory bodies, the treatment of mild to medium acne and spot correction is not considered a medical necessity. However, a rise in the affluence of the population has been fuelling the demand for aesthetic corrective procedures such as dermal filling, wrinkle reduction, volume restoration, and laser treatment.

Botulinum type-A injections and hyaluronic acid based dermal fillers are primarily used for aesthetically improving a person’s appearance.

The U.S. scar treatment market is also significantly gaining from the increasing demand for combination therapeutics in scar treatment to enhance the effectiveness of procedures and shorten the time taken for treatment.

The various products available in the U.S. scar treatment market include ointments, creams, gels, oils, and sprays. These products have proven helpful in reducing redness, bumps, pain, and itching caused by scars. Since these products can mostly be applied onto scars without any medical supervision, demand for them is quite high in the U.S. Additionally, the demand for minimally invasive surgical treatments and laser treatments has also significantly increased for the treatment of more severe scars.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12509

On the flip side, some of restraints witnessed by the market include the increasing awareness about the side effects associated with the usage of scar treatment products. The high cost of scar treatment therapies also has an adverse impact on the scar treatment market in the U.S.

U.S. Scar Treatment Market: Competitive Insight

To present insights into the prevailing competition in the U.S. scar treatment market, the report also profiles companies such as Valeant Pharmaceuticals International Inc., Johnson & Johnson Services, Oculus Innovative Sciences, Inc., and others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Uterine Fibroid Embolization Devices Market grows with increasing number of patients seeking UFE treatment

Global Uterine Fibroid Embolization Devices Market: Description

Uterine fibroid embolization (UFE) is a minimally invasive treatment used to treat fibroid tumors in the uterus. The uterine fibroid embolization procedure is also sometimes referred as a uterine artery embolization (UAE). UFE is also been used to treat other complications such as placenta accreta, placenta previa and arteriovenous malformations of the pelvis. Uterine fibroids are the most common benign tumor growths in the walls of the uterus (intramural fibroids), within the uterine cavity (sub mucosal fibroids) or on the serosal surface of uterus (subserosal fibroids). These fibroid tumors are also known as myomas and it is very rare for them to turn into cancerous tumors. The symptoms associated with these utreal fibroid tumors include heavy menstrual bleeding, pain in the back of legs, anemia, constipations, pain in the pelvic region, pressure on the bowel or bladder and other debilitating symptoms. Usually, uterine fibroids affect around 20% to 40% of women who are aged over 35 years.

The most common treatment options that are commercially available in the market for uterine fibroids include myomectomy (surgical removal of the fibroids) and hysterectomy (removal of entire uterus). The other treatment options that have shown moderate efficacy with some unwanted side effects in treating uterine fibroids include hormone therapy, myolysis (use of thermal energy to kill fibroid tissue), endometrial ablation and ultrasound therapy. In a typical UFE procedure, healthcare professionals use an x-ray camera known as fluoroscope to deliver the small particles to the uterus and fibroids. These small particles are injected through a flexible and thin tube called a catheter. Further, these block the arteries that provide blood flow, causing the fibroids to shrink. Approximately 90 percent of women with fibroids are experiencing relief of their symptoms with UFE procedure.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12566

Global Uterine Fibroid Embolization Devices Market: Drivers and Restraints

The market for uterine fibroid embolization devices is expected to show a huge growth potential in near future. The contributing factors behind such an assessment include increasing number of patients seeking UFE treatment, growing demand for the minimally invasive surgical treatment options, rise in base of geriatric population and growing healthcare awareness among the patients. Additionally, high treatment efficacy of UFE procedure compared to other treatment options, with a low risk of complications are likely to boost the growth of this market in future.

Global Uterine Fibroid Embolization Devices Market: Geographical Dynamics

Geographically, the North America region accounts for the largest share in the UFE devices market. North America is followed by Europe. The dominance of North America is attributable to a rapidly aging population that can afford to spend on expensive treatments.

Moreover, the presence of leading market players has proven favorable to North America gaining a leading position in the market. Additionally, growing healthcare awareness among the population and rising number of uterine fibroid patients further driving the growth of this market.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12566

However, the Asia-Pacific region is projected to report the fastest growth rate in this market the near future due to the high population in countries such as India and China. Greater awareness among patients will also create new growth opportunities. Additionally, a healthy medical tourism sector in countries such as India, Thailand, and Singapore and an overall rise in healthcare spending will back the growth of the Asian region. However, growth of this market might be hamstrung because of a lack proper reimbursement plans in developed countries.

Major players operating in this market include Boston Scientific Corporation, Merit Medical Systems, BioSphere Medical Inc., Hologic and Johnson & Johnson. Cook Medical, Ferring Pharmaceuticals, Conception Technologies, Smiths Medical and Smith & Nephew.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.